中国P站

HPLC; HPLC-MS; Drug Analysis; Quality Control; Pharmaceuticals; Environmental Pollutants; Food Contaminants; Clinical Diagnostics; Protein Analysis; Drug Discovery

Introduction

This article discusses the development and rigorous validation of an HPLC method designed for the simultaneous determination of nintedanib and its degradation products. The method proves to be stability-indicating, which is crucial for quality control in pharmaceutical production, ensuring accurate assessment of drug purity and stability in various dosage forms [1].

This review highlights recent advancements in HPLC-based methods for analyzing diverse food contaminants. The focus is on innovative sample preparation techniques and detection strategies that enhance sensitivity and selectivity, offering essential tools for ensuring food safety and quality control by identifying residues, toxins, and adulterants [2].

This comprehensive review delves into the application of High-Performance Liquid Chromatography coupled with Mass Spectrometry (HPLC-MS) for analyzing environmental pollutants. It covers various methodologies, sample preparation techniques, and the benefits of high-resolution mass spectrometry in identifying and quantifying a wide range of organic and inorganic contaminants in complex environmental matrices [3].

Here's a detailed account of a sensitive HPLC-UV method developed and validated for the simultaneous determination of three antiretroviral drugs in human plasma. This bioanalytical method is crucial for therapeutic drug monitoring and pharmacokinetic studies, ensuring accurate quantification of drug levels in biological samples to optimize treatment regimens [4].

This article offers a comprehensive review of HPLC-based approaches specifically tailored for quality control of traditional Chinese medicines. It explores various chromatographic techniques, detectors, and data analysis methods used to ensure the authenticity, purity, and consistency of complex herbal formulations, which is vital for therapeutic efficacy and safety [5].

High-Performance Liquid Chromatography coupled to Mass Spectrometry (HPLC-MS) continues to evolve as a cornerstone for routine screening and quantification of small molecules in clinical laboratories. This update highlights recent advances and diverse applications, demonstrating its irreplaceable role in diagnostics, therapeutic drug monitoring, and biomarker analysis [6].

This review explores the significant advancements in chiral high-performance liquid chromatography for drug analysis. It covers the evolution of chiral stationary phases, mobile phase optimization, and detection techniques, emphasizing their impact on separating enantiomers—a critical aspect in pharmaceutical development for drug efficacy and safety [7].

This study details the development and validation of an HPLC method capable of simultaneously determining multiple bioactive compounds in extracts of medicinal plants. The established method provides a reliable and precise tool for quality assessment, standardization, and pharmacological research of plant-derived natural products, facilitating their consistent use in medicine [8].

Recent advances in high-performance liquid chromatography for protein analysis and characterization are significant. This work reviews how HPLC, particularly when coupled with mass spectrometry, has become indispensable for separating, quantifying, and structurally elucidating proteins, which is fundamental for proteomics, biopharmaceutical development, and disease research [9].

This review paper provides an overview of HPLC-MS-based strategies crucial for drug discovery and development. It highlights how combining the separation power of HPLC with the detection capabilities of mass spectrometry facilitates high-throughput screening, metabolite identification, and pharmacokinetic profiling, accelerating the entire drug development pipeline [10].

Description

High-Performance Liquid Chromatography (HPLC) plays a central role in pharmaceutical quality control and drug analysis. A method was rigorously validated for the simultaneous determination of nintedanib and its degradation products, proving stability-indicating for quality control in production and ensuring accurate assessment of drug purity and stability [1]. Another sensitive HPLC-UV method was developed and validated for the simultaneous determination of three antiretroviral drugs in human plasma, essential for therapeutic drug monitoring and pharmacokinetic studies [4]. For traditional Chinese medicines, HPLC-based approaches are crucial for quality control, exploring various chromatographic techniques and detection methods to ensure authenticity, purity, and consistency of herbal formulations [5]. Additionally, significant advancements in chiral HPLC for drug analysis, including the evolution of chiral stationary phases and mobile phase optimization, impact the separation of enantiomers, which is critical for drug efficacy and safety in pharmaceutical development [7].

Beyond pharmaceuticals, HPLC-based methods are vital for public health and environmental monitoring. Recent advancements in HPLC-based methods for analyzing diverse food contaminants focus on innovative sample preparation and detection strategies, enhancing sensitivity and selectivity to ensure food safety and quality by identifying residues, toxins, and adulterants [2]. In environmental analysis, High-Performance Liquid Chromatography coupled with Mass Spectrometry (HPLC-MS) offers methodologies, sample preparation techniques, and high-resolution mass spectrometry benefits for identifying and quantifying a wide range of organic and inorganic contaminants in complex environmental matrices [3].

HPLC also serves as a cornerstone in clinical laboratories and for biological macromolecule analysis. What this really means is, HPLC-MS continues to evolve for routine screening and quantification of small molecules in clinical laboratories. This update highlights recent advances and diverse applications, demonstrating its irreplaceable role in diagnostics, therapeutic drug monitoring, and biomarker analysis [6]. Recent advances in high-performance liquid chromatography for protein analysis and characterization are significant, reviewing how HPLC, especially with mass spectrometry, is indispensable for separating, quantifying, and structurally elucidating proteins, fundamental for proteomics, biopharmaceutical development, and disease research [9].

Furthermore, HPLC methods support the study of natural products and accelerate drug discovery. A validated HPLC method determines multiple bioactive compounds in extracts of medicinal plants, providing a reliable tool for quality assessment, standardization, and pharmacological research of plant-derived natural products [8]. This review paper also provides an overview of HPLC-MS-based strategies crucial for drug discovery and development, highlighting how combining HPLC's separation power with mass spectrometry's detection capabilities facilitates high-throughput screening, metabolite identification, and pharmacokinetic profiling, thereby accelerating the entire drug development pipeline [10].

Conclusion

High-Performance Liquid Chromatography (HPLC) is a versatile analytical technique, fundamental across various scientific and industrial domains. It is extensively used in pharmaceutical quality control, exemplified by methods for determining drug purity, assessing stability of compounds like nintedanib and its degradation products, and simultaneously quantifying antiretroviral drugs in biological samples. The technique ensures the authenticity, purity, and consistency of pharmaceutical formulations, including traditional Chinese medicines. Its ability to separate enantiomers is crucial for drug efficacy and safety in development. Beyond pharmaceuticals, HPLC is vital for food safety, identifying contaminants such as residues, toxins, and adulterants through advanced detection strategies. In environmental analysis, HPLC coupled with Mass Spectrometry (HPLC-MS) offers comprehensive methodologies for quantifying organic and inorganic pollutants in complex matrices. Clinical laboratories increasingly rely on HPLC-MS for routine screening and quantification of small molecules, playing an irreplaceable role in diagnostics, therapeutic drug monitoring, and biomarker analysis. Furthermore, HPLC methods are developed for simultaneously determining bioactive compounds in medicinal plant extracts, supporting quality assessment and pharmacological research of natural products. The technique, especially when combined with mass spectrometry, is indispensable for protein analysis and characterization, aiding proteomics and biopharmaceutical development. HPLC-MS also drives drug discovery by enabling high-throughput screening, metabolite identification, and pharmacokinetic profiling, significantly accelerating development pipelines. Overall, HPLC continues to advance, offering enhanced sensitivity, selectivity, and broader applications across life sciences.

References

1. Koteswari M, Jyothi B, Sirisha K (2023) .Future J Pharm Sci 9:47.

   , ,

2. Maja J, Sne啪ana S, Miloš T (2022) .Food Chem 386:132890.

   , ,

3. Tian C, Min Z, Meng W (2021) .J Chromatogr A 1640:461971.

   , ,

4. Samuel OA, Gabriel UE, Kazeem SA (2023) .Bioanalysis 15:875-888.

   , ,

5. Jian L, Shanshan Z, Qian S (2022) .J Pharm Biomed Anal 216:114781.

   , ,

6. Andreia FS, Sandra A, Rute CP (2024) .Clin Chim Acta 552:117621.

   , ,

7. Hui C, Xiaojie W, Yonghong Z (2023) .J Pharm Biomed Anal 235:115714.

   , ,

8. Natalia K, Barbara S, Katarzyna M (2021) .Molecules 26:5463.

   , ,

9. Peipei F, Yuanfeng Z, Xiaoya W (2020) .TrAC Trends Anal Chem 133:116086.

   , ,

10. Xuan L, Ying W, Ming H (2019) .J Pharm Biomed Anal 174:433-447.

    , ,